Upregulation of tumor necrosis factor-alpha production by retrovirally transduced human tumor-infiltrating lymphocytes using trans-retinoic acid.
The ability of retinoic acid (RA) to upregulate gene expression in human tumor-infiltrating lymphocytes (TIL) transduced with a Moloney murine leukemia virus containing the cDNA encoding tumor necrosis factor (TNF) has been studied. TNF production was increased approximately twofold after treatment with RA. This increase was dose dependent and corresponded to a rise in the level of LTR-driven mRNA measured by Northern analysis. RA did not appreciably increase transcription by the SV40 promoter or increase endogenous TNF production. The effect lasted for 3-6 days following withdrawal of RA. These studies indicate that RA can upregulate LTR-driven gene expression in TIL cells bearing retroviral vectors and may thus be of use in studies of the gene therapy of cancer.
Surgery Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892.
J
J
Treisman
P
P
Hwu
J R
JR
Yannelli
G E
GE
Shafer
R
R
Cowherd
D
D
Samid
S A
SA
Rosenberg
D015870:Gene Expression / Q000187:drug effects; D005822:Genetic Vectors; D006801:Humans; D016246:Lymphocytes, Tumor-Infiltrating / Q000187:drug effects / Q000276:immunology*; D008979:Moloney murine leukemia virus / Q000235:genetics; D012333:RNA, Messenger / Q000235:genetics / Q000378:metabolism; D012091:Repetitive Sequences, Nucleic Acid; D014161:Transduction, Genetic; D014212:Tretinoin / Q000494:pharmacology*; D014409:Tumor Necrosis Factor-alpha / Q000096:biosynthesis* / Q000235:genetics*; D015854:Up-Regulation
D012333:RNA, Messenger; D014409:Tumor Necrosis Factor-alpha; D014212:Tretinoin